论文部分内容阅读
目的研究分析黛力新对功能性消化不良康复的影响。方法在该院2015年3月—2017年3月选取150例消化性不良患者,随机分为对照组与观察组各75例,对照组患者采取莫沙必利和雷贝拉唑进行治疗,观察组患者则是在对照组基础之上加入黛力新进行治疗,对两组患者的治疗效果进行比较。结果观察组患者治疗总有效率为96.0%,明显高于对照组67.9%(P<0.05),在症状总分值、抑郁自评量表以及焦虑自评量表对比中,观察组分别为(4.8±3.4)分、(39.4±2.7)分、(39.4±2.6)分,下降幅度明显大于对照组(P<0.05)。结论对功能性消化不良的患者应用黛力新,有助于提高治疗效率,降低患者抑郁以及焦虑程度,在临床中具有重要应用价值。
Objective To study the effects of Deanxit on functional dyspepsia. Methods From March 2015 to March 2017, 150 cases of patients with digestive disorders were selected and randomly divided into control and observation groups of 75 cases each. Patients in the control group were treated with mosapride and rabeprazole, and the observation group The patients were treated with Deanin on the basis of the control group, and the treatment effect was compared between the two groups. Results The total effective rate of observation group was 96.0%, which was significantly higher than that of control group (67.9%, P <0.05). In the total symptom score, depression self-rating scale and self-rating anxiety scale, the observation group were 4.8 ± 3.4) points, (39.4 ± 2.7) points and (39.4 ± 2.6) points, respectively. The decrease was significantly greater than that of the control group (P <0.05). Conclusion The application of Deanxit in patients with functional dyspepsia will help to improve the treatment efficiency and reduce the degree of depression and anxiety, which is of great value in clinical practice.